Unpacking the Role of Cannabis in Oncology as Reclassification of the Drug Pends
March 29th 2024Brooke Worster, MD, MS, FACP, and chief medical officer at EO Care, details what oncologists should know about medical cannabis pending the expectant marijuana reclassification from a Schedule I to a Schedule III drug.
Read More
Quad Shot Radiation Plus Immunotherapy Improves Local Control in Advanced Head and Neck Cancer
March 16th 2024Quad Shot radiation plus a checkpoint inhibitor significantly improved local control vs Quad Shot alone and was well tolerated as a palliative treatment for patients with advanced head and neck cancer.
Read More